REFERENCES
- Baldigo M, et al. Evaluating the impact on pharmacy practices of a law requiring the posting of drug prices. Journal of Consumer Affairs. 1980 Winter; 14: 463–70.
- Barnes, NJ. The pharmaceutical industry's experiment with a consumer advisory panel: An inside view. Health Care Management Review. 1984 Fall; 9(4):7–10.
- Beaden WO, Mason JB. Determinates of physician and pharmacist support of generic drugs. Journal of Consumer Research. 1980 June; 7:121–30.
- Carlson C, Hansen SO. Innovation and export market strate-gies in the pharmaceutical industry: A taxonomicat approach. Management International Review. 1982; 22(3):45–53,
- Carroll NV, Gagnon JP. Identifying consumer segments in health services markets: An application of conjoint and cluster analyses to the ambulatory care pharmacy market. Journal of Health Care Marketing. 1983 Summer; 3(3):22–34.
- Eckel F. Are we successfully marketing our profession? Top-ics in hospital pharmacy management. 1985 May; 5(1):86–88.
- Eisman M, Wardell W. The decline in effective patent life of new drugs. Research Management. 1981; 21(1):18–21.
- Gaedeke RM, Gordon CL. Marketing to public-aid recipi-ents: An examination of pharmacy profitability. Journal of Health Care Marketing. 1984 Fall; 4(4):17–21.
- Gagnon JP, Carroll NV. A strategy for marketing pharmacy services. American Pharmacy. 1982 January; 22(1):53–6.
- Glucksberg H, Singer J. The multinational drug companies in Zaire: Their adverse effect on cost and availability of essential drugs. International Journal of Health Services. 1982; 12(3):381–87.
- Grauer DW. Marketing concepts for pharmaceutical service development. American Journal of Hospital Pharmacy. 1981 February; 38(2):233–6.
- Houston MJ, Rothschild ML. Policy-related experiments on information provision: A normative model and explication. Journal of Marketing Research. 1980 November; 17:432–49.
- Kubicka AJ. Marketing management concepts for contem-porary pharmacy practice. Topics in Hospital Pharmacy Management. 1982 November; 2(3):55–65.
- Lambert ZV, et al. Predisposition toward generic drug acceptance. Journal of Consumer Research. 1980 June; 7:14–23.
- Mackowiak JP, Gagnon JP. Effects of promotion on phar-maceutical demand. Social Science and Medicine, 1985; 20(10:1191–97.
- Mason 7B, Bearden WO. Generic drugs: consumer, phar-macist and physician perception of the issues. Journal of Consumer Affairs. 1980 June; 14: 193–206.
- Parsons U, Abeele PV. Analysis of sales call effectiveness. Journal of Marketing Research. 1983 February; 19:595–8.
- Pathak DS. Integrating strategic planning and marketing for hospital pharmacy directors, Topics in Hospital Pharmacy Management. 1985 May; 5(1):8–24.
- Sawyer DO. Pharmaceutical reimbursement and drug cost control: The MAC experience in Maryland. Inquiry. 1983 Spring; 20(1):76–87.
- Schmelling DG, Wotring CE. Making anti-drug-abuse ad-vertising work. Journal of Advertising Research. 1980 June; 20:33–7.
- Smith JE, Sheaffer SL. Marketing clinical pharmacy ser-vices. Topics in Hospital Pharmacy Management, 1985 May; 5(1):53–62.
- Statemen M, Tyebjee TT . Strategic responses to changes in public policy: The case of the pharmaceutical industry and drug substitution laws. Journal of Public Policy and Market-ing. 1984; 3:99–112.
- Temin P. Costs and benefits in switching drugs from Rx to OTC. Journal of Health Economics. 1983; 2:187–205.
- von Grehmer K. Competition in a structurally changing pharmaceutical market: Some health economic consider-ations. Social Science and Medicine. 1981; 15C:77–86.
- Walton H. Ad recognition and prescribing by physicians. Journal of Advertising Research. 1980 June; 20(3):39–48.
- Wardell W, Diraddo J, Trimble GA. Development of new drugs originated and acquired by United States-owned phar-maceutical firms, 1963–1976. Clinical Pharmacology and Therapeutics. 1980 August; 28(2):270–277.